DTP hepatitis B vaccine/Hib-meningococcal vaccine (GlaxoSmithKline)

N/A

Report date: 2022/07/18 14:26:12

Base Information

Drug NameDTP hepatitis B vaccine/Hib-meningococcal vaccine (GlaxoSmithKline)
Drug Alias NameGloborix
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BStreptococcal InfectionsTetanus +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnamEUGambia
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHepatitis BStreptococcal InfectionsTetanus +[8] 

Other Information

ATC CodeN/A
Related LinksN/A